8-KThe WireRoutine
Bylaw Amendment · Company Update
Filed Oct 20, 2020 · 5y ago · Accession 0001193125-20-272852
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Aligos Therapeutics, Inc.
- Ticker
- ALGS
- CIK
- 1799448
- Form type
- 8-K
- Filing date
- Oct 20, 2020
- Report date
- Oct 20, 2020
- Document
- d46540d8k.htm
- Size
- 234 KB